Lv3
230 积分 2024-01-16 加入
Cancer incidence and mortality in China, 2022
12小时前
待确认
Faculty Opinions recommendation of Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
1个月前
已关闭
Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
1个月前
已完结
Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
2个月前
已完结
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
2个月前
已完结
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
2个月前
已完结
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
2个月前
已完结
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2个月前
已完结
Comparative genomics reveals 104 candidate structured RNAs from bacteria, archaea, and their metagenomes
3个月前
已关闭
Carcinoma of the breast: its treatment and prevention
3个月前
已关闭
皖公网安备34019202002308
